Research teams separated by 14 hours and 9000 miles have collaborated to advance prospective treatment for the world’s moment-main cause of death. University of Nebraska-Lincoln chemists partnered with medical researchers from the National University of Singapore to develop a molecule that can inhibit (restrain; prohibit; retard or prevent) an enzyme linked with the onset of stroke. Most strokes occur when [...]
Source: psypost.org